Melody Chang, R.Ph., says payers cover bispecific and CAR-T drugs but not the monitoring that lets community practices deliver them safely at lower cost.
|Articles|June 14, 2020
AstraZeneca's Adrian Kilcoyne Discusses Lung Cancer, Screening (pt.3)
Author(s)Briana Contreras, Peter Wehrwein
Advertisement
Adrian Kilcoyne MD MBA MPH, vice president, US Medical Affairs and HEOR, oncology, AstraZeneca, discusses the process of screening for lung cancer and the populations who are screened. This topic was presented at the American Society of Clinical Oncology's annual conference which was held virtually this year in late May.
Advertisement
Related to this article
American Oncology Network’s Melody Chang, R.Ph., says 18% of its first 70 outpatient bispecific patients had CRS, all low grade with no hospitalizations.
Consistent bedtime routines, screen-free bedrooms and therapist support for night waking help children with ADHD sleep better, said Alison Pritchard, Ph.D.
Jamilia Sherls, DNP, MPH, RN, CPN, CDP, of Washington’s health department says health systems should look to AAP and AAFP schedules and build on patients’ trust in providers.
Jamilia Sherls, DNP, MPH, RN, CPN, CDP, of Washington’s health department says a stayed schedule overhaul cutting recommended child vaccines from 17 to 11 could upend coverage.
The American College of Chest Physicians and the European Respiratory Society issued bronchiectasis guidelines recently. Here is a comparison.
Experts discussed guidelines from the American College of Chest Physicians and the European Respiratory Society at the 2026 CHEST meeting in Phoenix earlier this week.
Continuous glucose monitoring cut mean A1C from 8.8% to 7.2% over 26 weeks in adults with type 2 diabetes not on insulin, 0.9 points more than routine care in the CONNECT trial.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
2
Jessica Castle, M.D., discusses CGM’s A1C impact in non-insulin type 2 diabetes
3
Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations
4
International guidance and new European data back type 1 diabetes screening for all children
5